Concepedia

Kerstin Guenther

KG

Statistics

Publications

3

Citations

185

H-Index

3

Active since

2020

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Immatics Biotechnologies (Germany)

Kerstin Guenther is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, t cell immunity, and tumor immunity.

ORCID

Top concepts

Publications per year

2020–2023

3

Publications

3

Genome‐wide cooperation of <scp>EMT</scp> transcription factor <scp>ZEB</scp> 1 with <scp>YAP</scp> and <scp>AP</scp> ‐1 in breast cancer

Nora Feldker, Fulvia Ferrazzi, Harald Schuhwerk et al. · The EMBO Journal · 2020 · 155 citations · Full text

959 Safety and anti-tumor activity of TCR-engineered autologous, PRAME-directed T cells across multiple advanced solid cancers at low doses – clinical update on the ACTengine® IMA203 trial

Martin Wermke, Apostolia M. Tsimberidou, Ali Mohamed et al. · 2021 · 17 citations · Full text

, , +22

Feasibility and Safety of Personalized, Multi-Target, Adoptive Cell Therapy (IMA101): First-in-Human Clinical Trial in Patients with Advanced Metastatic Cancer

Apostolia M. Tsimberidou, Kerstin Guenther, Börje S. Andersson et al. · Cancer Immunology Research · 2023 · 13 citations · Full text

1–3 of 3